CE: Glucagon as an Underutilized Approach: Advancing the Management of Severe Hypoglycemia

This activity is supported by an independent educational grant from Xeris Pharmaceuticals, Inc.

FACULTY

Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, BCACP, Endocrine Clinical Pharmacy Specialist at the Cleveland Clinic Endocrinology & Metabolism Institute Diabetes Center in Cleveland, Ohio.

EDUCATIONAL OBJECTIVES

At the completion of this activity, the participant will be able to:

• Identify the risk factors, signs and symptoms, and classifications of hypoglycemia
• Examine the management options for hypoglycemia and common barriers that affect patient outcomes
• Explore the safety, efficacy, and clinical benefits of new agents used for severe hypoglycemia
• Optimize the role of the pharmacist in educating patients and caregivers on recommended treatment strategies for severe hypoglycemia to improve patient outcomes

TARGET AUDIENCE: Community pharmacists and long-term care pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: February 14, 2020

EXPIRATION DATE: February 14, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.5 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.